Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vector BioMed

Explore full profile

Superior Gene Delivery Systems Empowering Tomorrow’s Gene Medicine Cures

Gaithersburg, United StatesHealth
Valuation $50–100M Last recorded · 2022
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Vector BioMed and the history behind them.

About Vector BioMed

Vector BioMed specializes in the development and commercialization of gene therapies through custom Lentiviral vector manufacturing. The company serves researchers and pharmaceutical companies by providing tailored solutions for gene delivery, particularly for CAR T cell therapies and Stem Cell gene therapies. Operating in the biotechnology and pharmaceutical markets, Vector BioMed's business model revolves around offering bespoke vector design and GMP (Good Manufacturing Practice) manufacturing services. Revenue is generated through the provision of these specialized services, which include designing optimal Lentiviral vector candidates to meet specific therapeutic targets. The company prides itself on delivering high-quality, safe, and effective gene delivery systems.

Source: Dealroom company data

At a glance

Status
Operational
Headquarters
Gaithersburg, United States
Open positions
2
Dealroom signal
22.9/100
Industry
Health
Sector
Health, Hard Tech
Business model
Manufacturing
Client focus
b2b
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Dec 2022 $15M $60M Casdin Capital · Viking Global Investors ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Vector BioMed website traffic

Latest recorded traffic for Vector BioMed is 2K monthly website visits, up 66.7% over the last three months.

Latest monthly visits2K 3-month web change+66.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Gaithersburg HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vector BioMed on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vector BioMed’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.